MyTelcare Diabetes Pal app now available
BETHESDA, Md. — A provider of mobile health solutions has introduced a free application that synchronizes with a wireless blood-glucose meter.
The MyTelcare Diabetes Pal, now available via the Apple App Store, allows patients and caregivers to use their iPhone, iPod Touch and/or iPad to visualize every glucose reading sent by the Telcare BGM (blood-glucose meter) while tracking medication, nutrition, activities and notes. What’s more, the app also enables patients who don’t have the Telcare BGM to manually enter their blood-glucose data and track it over time.
“Telcare’s free app is designed to empower every patient by eliminating the hurdles that have made the analysis of glucose readings so time consuming,” Telcare CEO Jonathan Javitt said. “We want to increase patients’ understanding of their diabetes and help them and their caregivers properly manage the disease. The support of endocrinologists and diabetes educators around the world verifies the need for this application. We believe this app’s innovative and intuitive design will help people with diabetes change behavior and as a result improve their health.”
Study: Genetic predisposition to dyslipidemia associated with Type 2 diabetes risk
ATLANTA — People that are genetically predisposed to developing a condition that causes high blood cholesterol levels may be at an increased risk of developing Type 2 diabetes, according to a new study.
The study, published in the journal Diabetes, was led by Qibin Qi of the Harvard School of Public Health in Boston and included 2,447 patients with Type 2 diabetes and 3,052 control participants of European ancestry from the Nurses’ Health Study and the Health Professionals Follow-up Study. Researchers found that the genetic predisposition to dyslipidemia, a lipid disorder caused by high cholesterol, was estimated by three genotype scores of lipids: LDL cholesterol, HDL cholesterol and triglycerides. Qi and colleagues found, however, that among the three scores, HDL cholesterol and triglyceride genotype scores were related to elevated Type 2 diabetes risk of 3% and 2%, respectively.
"In conclusion, genetic predisposition to low HDL cholesterol or high triglycerides is related to elevated type 2 diabetes risk," the researchers said.
Click here to access the full study results.
Mylan to challenge court decision over generic asthma, COPD drug
PITTSBURGH — Generic drug maker Mylan plans to challenge a court decision that requires it to pay almost $20 million to a drug company whose product it tried to market as a generic.
Sunovion Pharmaceuticals sued Mylan and several subsidiaries in the U.S. District Court for the District of Delaware when the latter sought to market a generic version of Sunovion’s Xopenex (levalbuterol hydrochloride) inhalation solution, a drug for asthma and chronic obstructive pulmonary disease. The jury’s verdict includes an $18 million award.
"While this is not a significant product for Mylan, we firmly believe that the jury has erred and intend to seek reversal through post-trial motions and, if necessary, an appeal of the verdict and the damages award," Mylan CEO Heather Bresch said.